Erlotinib vs Methylprednisolone
Erlotinib vs Methylprednisolone: Overview
This comparison examines the pharmacological differences between Erlotinib and Methylprednisolone.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Methylprednisolone β 18-36 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Methylprednisolone β C22H30O5.
Molecular Weight: Erlotinib β 393.4380 g/mol; Methylprednisolone β 374.4710 g/mol.
Type: Erlotinib β Small molecule; Methylprednisolone β Small molecule.